Scientific Program

Filter Results:

Show Only CME Accredited Sessions

  • +

    IASLC Foundation Walk supported by Lung Cancer Canada (Ticketed Event)

    • Type: Networking Opportunity
    • Track:
    • +

      Registration Opens

      07:00 - 08:00

      • Abstract

      Abstract not provided

    • +

      Shotgun Start

      08:00 - 09:30

      • Abstract

      Abstract not provided

    • +

      Celebration and Breakfast/Snacks

      09:30 - 11:00

      • Abstract

      Abstract not provided

  • +

    S01 - IASLC CT Screening Symposium: Forefront Advances in Lung Cancer Screening (Ticketed Session)

    • Type: Symposium
    • Track: Screening and Early Detection
    • +

      S01.01 - Breakfast

      07:00 - 07:30

      • Abstract

      Abstract not provided

    • +

      S01.02 - Introductions & Welcome

      07:30 - 07:35

      • Abstract

      Abstract not provided

    • +

      S01.03 - Session I: The Backbone to our Knowledge on Lung Cancer Screening

      07:35 - 07:35

      • Abstract

      Abstract not provided

    • +

      S01.04 - Lung Cancer Screening: 1999 to Date – What Have We Learnt?

      07:35 - 07:50  |  Presenting Author(s): David F Yankelevitz

      • Abstract

      Loading...

    • +

      S01.05 - Discussion

      07:50 - 08:00

      • Abstract

      Abstract not provided

    • +

      S01.06 - Session II: Future Integration of Biomarkers in the Selection of High Risk Individuals for Lung Cancer Screening

      08:00 - 08:00

      • Abstract

      Abstract not provided

    • +

      S01.07 - The U19 Plans for Integration of Biomarkers into Future Lung Cancer Screening

      08:00 - 08:50  |  Presenting Author(s): Rayjean J. Hung, Paul Brennan, Christopher Ian Amos

      • Abstract

      Abstract not provided

    • +

      S01.08 - Discussion

      08:50 - 09:00

      • Abstract

      Abstract not provided

    • +

      S01.09 - Session III: European Strategy for the Implementation of Lung Cancer Screening

      09:00 - 09:00

      • Abstract

      Abstract not provided

    • +

      S01.10 - EU Position Statement on Lung Cancer Screening

      09:00 - 09:20  |  Presenting Author(s): Matthijs Oudkerk

      • Abstract

      Abstract not provided

    • +

      S01.11 - Discussion

      09:20 - 09:30

      • Abstract

      Abstract not provided

    • +

      S01.12 - Coffee Break

      09:30 - 09:50

      • Abstract

      Abstract not provided

    • +

      S01.13 - Session IV: Lung Cancer Screening Requires Infra-Structural Organisation and an Integrated Smoking Cessation Plan

      09:50 - 09:50

      • Abstract

      Abstract not provided

    • +

      S01.14 - Coordination of the Lung Cancer CT Screening Experience

      09:50 - 10:05  |  Presenting Author(s): Joelle Thirsk Fathi

      • Abstract

      Abstract not provided

    • +

      S01.15 - Integration of Smoking Cessation into Lung Cancer Screening

      10:05 - 10:20  |  Presenting Author(s): Kate Brain

      • Abstract

      Abstract not provided

    • +

      S01.16 - Discussion

      10:20 - 10:30

      • Abstract

      Abstract not provided

    • +

      S01.17 - Session V: Panel Discussion: Next Steps for Lung Screening?

      10:30 - 11:30  |  Presenting Author(s): Claudia I Henschke, Kwun M Fong, Motoyasu Sagawa, Matthew Eric Callister, Nasser Altorki, Bruce Pyenson, Andrea Katalin Borondy Kitts

      • Abstract

      Abstract not provided

    • +

      S01.18 - IASLC Leads the International Collaboration on Data Sharing (IASLC- ELIC-CCTRR)

      11:30 - 11:50  |  Presenting Author(s): John Kirkpatrick Field, James L Mulshine

      • Abstract

      Abstract not provided

    • +

      S01.19 - Discussion

      11:50 - 12:00

      • Abstract

      Abstract not provided

    • +

      S01.20 - Networking Lunch

      12:00 - 12:00

      • Abstract

      Abstract not provided

  • +

    JCSE01 - Perspectives for Lung Cancer Early Detection

    • Type: Joint IASLC/CSCO/CAALC Session
    • Track: Screening and Early Detection
  • +

    WS01 - Cancer Genomics Workshop (Ticketed Session)

    • Type: Workshop
    • Track:
    • +

      WS01.01 - Introduction to the Workshop

      08:00 - 08:15

      • Abstract

      Abstract not provided

    • +

      WS01.02 - Exercise 1: Cancer Gene Panels: Methods and Application

      08:15 - 09:30

      • Abstract

      Abstract not provided

    • +

      WS01.03 - Break

      09:30 - 09:45

      • Abstract

      Abstract not provided

    • +

      WS01.04 - Exercise 2: Cancer Gene Panels: Result Interpretation and Clinical Utility

      09:45 - 11:00

      • Abstract

      Abstract not provided

    • +

      WS01.05 - Questions/Panel Discussion

      11:00 - 11:15

      • Abstract

      Abstract not provided

  • +

    WS02 - Mesothelioma Workshop

    • Type: Workshop
    • Track: Mesothelioma
    • +

      WS02.01 - Session 1: Surgery for Mesothelioma

      08:00 - 08:00  |  Presenting Author(s): Harvey Pass

      • Abstract

      Abstract not provided

    • +

      WS02.02 - What Are the Most Important Unmet Needs in the Surgical Management of Mesothelioma?

      08:00 - 08:15  |  Presenting Author(s): Valerie W Rusch

      • Abstract

      Abstract not provided

    • +

      WS02.03 - Who Are the High Risk Patients for Surgical Failure in Mesothelioma?

      08:15 - 08:30  |  Presenting Author(s): Harvey Pass

      • Abstract

      Abstract not provided

    • +

      WS02.04 - SMART, Where It Is Going

      08:30 - 08:45  |  Presenting Author(s): Marc De Perrot

      • Abstract

      Abstract not provided

    • +

      WS02.05 - Reliability of MM Diagnosis and Role of BAP1 Staining

      08:45 - 09:00  |  Presenting Author(s): Francoise Galateau-Salle

      • Abstract

      Abstract not provided

    • +

      WS02.06 - Q&A

      09:00 - 09:05

      • Abstract

      Abstract not provided

    • +

      WS02.07 - Session 2: Immunotherapy in Mesothelioma

      09:05 - 09:05  |  Presenting Author(s): Paul Baas

      • Abstract

      Abstract not provided

    • +

      WS02.08 - The Microenvironment and Mesothelioma

      09:05 - 09:20  |  Presenting Author(s): Prasad S. Adusumilli

      • Abstract

      Abstract not provided

    • +

      WS02.09 - PDL-1 and Mesothelioma

      09:20 - 09:35  |  Presenting Author(s): Raphael Bueno

      • Abstract

      Abstract not provided

    • +

      WS02.10 - An Overview of Present and Future Immunotherapy Trials in Mesothelioma: Progress and Problems

      09:35 - 09:50  |  Presenting Author(s): Aaron S. Mansfield

      • Abstract

      Abstract not provided

    • +

      WS02.11 - Window of Opportunity Immunotherapy Trials in Mesothelioma: Design and Translation

      09:50 - 10:05  |  Presenting Author(s): Anne S. Tsao

      • Abstract

      Abstract not provided

    • +

      WS02.12 - Q&A

      10:05 - 10:10

      • Abstract

      Abstract not provided

    • +

      WS02.13 - Session 3: Transcriptome Changes and Mutations in Mesothelioma - Somatic, Germline, BAP1 and more

      10:10 - 10:10  |  Presenting Author(s): David Mark Jablons

      • Abstract

      Abstract not provided

    • +

      WS02.14 - BAP1 Mutations: Mechanisms and Significance

      10:10 - 10:25  |  Presenting Author(s): Michele Carbone

      • Abstract

      Abstract not provided

    • +

      WS02.15 - Novel Approaches for Targeting BAP1

      10:25 - 10:40  |  Presenting Author(s): Marjorie G. Zauderer

      • Abstract

      Abstract not provided

    • +

      WS02.16 - Genome-wide Silencing Screen in Mesothelioma Cells Reveals that Loss of Function of BAP1 Induces Chemoresistance to Ribonucleotide Reductase Inhibition: Implication for Therapy

      10:40 - 10:55  |  Presenting Author(s): Emanuela Felley-Bosco

      • Abstract

      Abstract not provided

    • +

      WS02.17 - A Subset of Mesotheliomas with Improved Survival Occurring in Carriers of BAP1 and of other Germline Mutations

      10:55 - 11:10  |  Presenting Author(s): Haining Yang

      • Abstract

      Abstract not provided

    • +

      WS02.18 - Q&A

      11:10 - 11:15

      • Abstract

      Abstract not provided

  • +

    WS03 - Endoscopic Diagnosis and Staging of Lung Cancer – Interventional Pulmonology Hands-On Workshop (Ticketed Session)

    • Type: Workshop
    • Track: Interventional Diagnostics/Pulmonology
    • +

      WS03.01 - Welcome and Introduction

      08:00 - 08:10

      • Abstract

      Abstract not provided

    • +

      WS03.02 - EBUS-TBNA – Role in Invasive Mediastinal Staging

      08:10 - 08:30  |  Presenting Author(s): Kazuhiro Yasufuku

      • Abstract

      Abstract not provided

    • +

      WS03.03 - Combined EBUS/EUS Mediastinal Staging

      08:30 - 08:50  |  Presenting Author(s): Waël C. Hanna

      • Abstract

      Abstract not provided

    • +

      WS03.04 - Radial Probe EBUS – Methods and Results

      08:50 - 09:10  |  Presenting Author(s): Kasia Czarnecka-Kujawa

      • Abstract

      Abstract not provided

    • +

      WS03.05 - Navigational Bronchoscopy

      09:10 - 09:30  |  Presenting Author(s): Laura Donahoe

      • Abstract

      Abstract not provided

    • +

      WS03.06 - Hands-On Session on 4 stations

      09:30 - 11:30

      • Abstract

      Abstract not provided

  • +

    WS04 - Roche Scientific Symposium: Clinical Decision Support for Management of Lung Cancer Patients and Future Directions in the Era of Precision Medicine (Sign Up Required) (Not IASLC CME Accredited)

    • Type: Workshop
    • Track:
    • +

      WS04.01 - Welcome & Introduction

      08:00 - 08:15

      • Abstract

      Abstract not provided

    • +

      WS04.02 - Protein-based Biomarkers as Tools to Support Clinical Decision Making for Lung Cancer Patients with Results from the Laboratory

      08:15 - 08:45  |  Presenting Author(s): Rafael Molina

      • Abstract

      Abstract not provided

    • +

      WS04.03 - Using Immunohistochemistry in Differential Diagnosis and Predictive Assessment of Lung Cancer

      08:45 - 09:15  |  Presenting Author(s): Mark Kockx

      • Abstract

      Abstract not provided

    • +

      WS04.04 - Clinical Utility of Liquid Biopsy to EGFR Mutation Detection in NSCL

      09:15 - 09:45  |  Presenting Author(s): Adrian Sacher

      • Abstract

      Abstract not provided

    • +

      WS04.05 - Break

      09:45 - 10:00

      • Abstract

      Abstract not provided

    • +

      WS04.06 - Circulating Tumor DNA: Solid Tumor MRD Detection and Potential Clinical Utility

      10:00 - 10:30  |  Presenting Author(s): Aadel Chaudhuri

      • Abstract

      Abstract not provided

    • +

      WS04.07 - University of Missouri’s Experience with the NAVIFY Tumor Board Solution in HemOnc Tumor Board

      10:30 - 11:00  |  Presenting Author(s): Richard Hammer

      • Abstract

      Abstract not provided

    • +

      WS04.08 - Panel Discussion

      11:00 - 11:30

      • Abstract

      Abstract not provided

  • +

    YI01 - Young Investigators Session

    • Type: Young Investigator Session
    • Track:
    • +

      YI01.01 - Introduction to the IASLC - Why You Should be a Member

      08:00 - 08:10  |  Presenting Author(s): Clarissa Mathias

      • Abstract

      Abstract not provided

    • +

      YI01.02 - Planning a Career in Lung Cancer - Clinical Trials

      08:10 - 08:20  |  Presenting Author(s): Roy S. Herbst

      • Abstract

      Abstract not provided

    • +

      YI01.03 - Planning a Career in Lung Cancer - Science

      08:20 - 08:30  |  Presenting Author(s): Yolonda Colson

      • Abstract

      Abstract not provided

    • +

      YI01.04 - Planning a Career in Lung Cancer - Bench to Beside

      08:30 - 08:40  |  Presenting Author(s): Pasi A Jänne

      • Abstract

      Abstract not provided

    • +

      YI01.05 - Planning a Career in Lung Cancer - Education

      08:40 - 08:50  |  Presenting Author(s): Barbara Melosky

      • Abstract

      Abstract not provided

    • +

      YI01.06 - Community Oncology

      08:50 - 09:00  |  Presenting Author(s): Parneet Kaur Cheema

      • Abstract

      Abstract not provided

    • +

      YI01.07 - Making the Most of your Cooperative Group

      09:00 - 09:10  |  Presenting Author(s): Rolf A Stahel

      • Abstract

      Abstract not provided

    • +

      YI01.08 - Panel Discussion

      09:10 - 09:30

      • Abstract

      Abstract not provided

    • +

      YI01.09 - Break

      09:30 - 09:45

      • Abstract

      Abstract not provided

    • +

      YI01.10 - Knowing your Statistics

      09:45 - 10:00  |  Presenting Author(s): Mary W. Redman

      • Abstract

      Abstract not provided

    • +

      YI01.11 - How to get your Paper Published

      10:00 - 10:15  |  Presenting Author(s): Alex Adjei

      • Abstract

      Abstract not provided

    • +

      YI01.12 - Writing a Successful Abstract

      10:15 - 10:30  |  Presenting Author(s): Michael Boyer

      • Abstract

      Abstract not provided

    • +

      YI01.13 - How to give a Great Presentation

      10:30 - 10:45  |  Presenting Author(s): Tony S. Mok

      • Abstract

      Abstract not provided

    • +

      YI01.14 - How to write a Successful Grant Application

      10:45 - 11:00  |  Presenting Author(s): Dean A Fennell

      • Abstract

      Abstract not provided

    • +

      YI01.15 - Panel Discussion

      11:00 - 11:15

      • Abstract

      Abstract not provided

    • +

      YI01.16 - Young investigator Experience

      11:15 - 11:20  |  Presenting Author(s): Fabio Y Moraes

      • Abstract

      Abstract not provided

    • +

      YI01.17 - Getting the most out of WCLC 2018

      11:20 - 11:30  |  Presenting Author(s): Anne-Marie Baird

      • Abstract

      Abstract not provided

    • +

      YI01.18 - Close

      11:30 - 11:30

      • Abstract

      Abstract not provided

  • +

    ISS01 - Symposium Supported by Takeda: New Insights and Clinical Implications for the Treatment of ALK+ NSCLC (Not IASLC CME Accredited)

    • +

      Welcome and Introductions

      09:45 - 09:52  |  Presenting Author(s): Natasha B Leighl

      • Abstract

      Abstract not provided

    • +

      Insights Into Mechanisms of Resistance and Characterizing Oncogenic Drivers in ALK+ NSCLC

      09:52 - 10:14  |  Presenting Author(s): Robert C. Doebele

      • Abstract

      Abstract not provided

    • +

      Current Landscape of ALK Inhibitors and Key Data

      10:14 - 10:36  |  Presenting Author(s): Karen L. Reckamp

      • Abstract

      Abstract not provided

    • +

      How to Integrate New Agents and Disease Monitoring Practices Into Optimal Patient Care

      10:36 - 10:58  |  Presenting Author(s): Luis Paz-Ares

      • Abstract

      Abstract not provided

    • +

      Panel Discussion

      10:58 - 11:13  |  Presenting Author(s): Natasha B Leighl, Robert C. Doebele, Luis Paz-Ares, Karen L. Reckamp

      • Abstract

      Abstract not provided

    • +

      Conclusion

      11:13 - 11:15  |  Presenting Author(s): Natasha B Leighl

      • Abstract

      Abstract not provided

  • +

    ISS02 - Symposium Supported by Incyte: Novel Immunotherapy Strategies in Lung Cancer (Not IASLC CME Accredited)